✦ LIBER ✦

Effect of maintenance therapy with low-dose peginterferon for recurrent hepatitis C after living donor liver transplantation

✍ Scribed by Y. Ueda; H. Marusawa; T. Kaido; Y. Ogura; F. Oike; A. Mori; K. Ogawa; A. Yoshizawa; E. Hatano; A. Miyagawa-Hayashino; H. Haga; H. Egawa; Y. Takada; S. Uemoto; T. Chiba

Book ID: 108886540
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 232 KB
Volume: 19
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2010.01398.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical features of biochemical cholest

Clinical features of biochemical cholestasis in patients with recurrent hepatitis C after living-donor liver transplantation

✍ Y. Ueda; Y. Takada; H. Marusawa; H. Haga; T. Sato; Y. Tanaka; H. Egawa; S. Uemot 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Effects of double-filtration plasmaphere

Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation

✍ Yasutsugu Takada; Takashi Ito; Yoshihide Ueda; Hironori Haga; Hiroto Egawa; Koic 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Response rates to interferon and ribavirin treatment for recipients with recurrent hepatitis C virus (HCV) infection are suboptimal, particularly for those with genotype 1b and high viral load. The present study evaluated the effects of combining double-filtration plasmapheresis (DFPP) with pharmaco

Prevention of hepatitis B recurrence aft

Prevention of hepatitis B recurrence after living donor liver transplantation: Primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy

✍ Shin Hwang; Sung-Gyu Lee; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 1 views

The prevention of hepatitis B virus (HBV) recurrence is essential after liver transplantation in patients infected with HBV. We evaluated the efficacy of primary high-dose hepatitis B immunoglobulin (HBIG) monotherapy and rescue antiviral therapy in 639 HBV-infected adult patients who underwent livi

Immunohistochemical staining of liver gr

Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation

✍ Hiroshi Sadamori; Takahito Yagi; Hiromi Iwagaki; Hiroaki Matsuda; Susumu Shinour 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 512 KB

Lamivudine therapy in patients undergoin

Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu

✍ McCaughan, Geoffrey W. ;Spencer, Jenean ;Koorey, David ;Bowden, Scott ;Bartholom 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 75 KB 👁 1 views

Recurrent hepatitis B virus (HBV) infection remains a major cause of morbidity and mortality after liver transplantation. Recently, antiviral therapy, such as lamivudine, has become available for prophylaxis against HBV reactivation posttransplantation and for the treatment of HBV recurrent disease.